Tarceva (erlotinib) May 2009 Dear Healthcare Professional letter issued to warn about GI perforation, exfoliative skin conditions and corneal perforation/ulceration.
Source: www.fda.govCE Mark Extended For Disc Dynamics' DASCOR(R) Disc Arthroplasty System Disc Dynamics, Inc., a leading developer of minimally invasive treatment options for low back pain caused by degenerative disc disease (DDD), announced that the CE Mark received in the European Union for its DASCOR® Disc Arthroplasty System has been expanded to incorporate a posterior-lateral surgical approach, as well as an endoscopic approach.
Source: www.medicalnewstoday.comDigoxin, USP 0.125 mg, Digoxin, USP 0.25 mg (Caraco brand) Source: www.fda.gov
# posted by Network @ 10:14 PM
